<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35346298</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-6606</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>28</Day></PubDate></JournalIssue><Title>Molecular brain</Title><ISOAbbreviation>Mol Brain</ISOAbbreviation></Journal><ArticleTitle>Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>25</StartPage><MedlinePgn>25</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">25</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13041-022-00914-x</ELocationID><Abstract><AbstractText>The activation and dysregulation of retrotransposons has been identified in the CNS of individuals with the fatal neurodegenerative disorder Amyotrophic lateral sclerosis (ALS). This includes elements from multiple different families and subfamilies of retrotransposons, however there is limited knowledge of the specific loci from which this expression occurs in ALS. The long interspersed element-1 (L1) is the only autonomous retrotransposon in the human genome and members of this family of elements maintain the ability to mobilise. Despite L1s contributing to 17% of the human genome only 80-100 L1s encode the required proteins for mobilisation and are retrotransposition competent. Identifying the specific loci from which L1 expression occurs will inform on the potential functional consequences of their expression, such as the potential for somatic retrotransposition or DNA damage caused by the endonuclease activity of the ORF2 protein of the L1. Here we characterised L1 loci expression using the L1EM tool ( https://github.com/FenyoLab/L1EM ) in RNA sequencing data from 518 samples across four tissues (motor cortex, frontal cortex, cerebellum and cervical spinal cord) in the Target ALS cohort obtained from the New York Genome Center. There was a significant reduction in total intact L1 expression (those that encode functional proteins) in two brain regions of individuals with ALS compared to controls and clustering of the ALS brain regions occurred based on their intact L1 expression profile. Although overall the levels of L1 expression were reduced in ALS/ALS with other neurological disorder (ND) there were individuals in which L1s were expressed at much higher levels than the rest of the ALS/ALSND cohort. Expressed L1 loci were more frequently located in introns compared to those not expressed and the level of L1 expression positively correlated with the expression of the gene in which it was located. Significant differences were observed in the expression profiles of L1s in ALS and specific features of these elements, such as location in the genome and whether or not they are intact, were significantly associated with those that were expressed in the cohort.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pfaff</LastName><ForeName>Abigail L</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-2231-9800</Identifier><AffiliationInfo><Affiliation>Perron Institute for Neurological and Translational Science, Perth, 8 Verdun Street, Nedlands, WA, 6009, Australia. Abigail.pfaff@uwa.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, Australia. Abigail.pfaff@uwa.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bubb</LastName><ForeName>Vivien J</ForeName><Initials>VJ</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>John P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koks</LastName><ForeName>Sulev</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Perron Institute for Neurological and Translational Science, Perth, 8 Verdun Street, Nedlands, WA, 6009, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Brain</MedlineTA><NlmUniqueID>101468876</NlmUniqueID><ISSNLinking>1756-6606</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018626">Retroelements</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015894" MajorTopicYN="N">Genome, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020084" MajorTopicYN="N">Long Interspersed Nucleotide Elements</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018626" MajorTopicYN="N">Retroelements</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Expression</Keyword><Keyword MajorTopicYN="N">Long interspersed element-1 (LINE-1/L1)</Keyword><Keyword MajorTopicYN="N">Retrotransposon</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>29</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35346298</ArticleId><ArticleId IdType="pmc">PMC8961898</ArticleId><ArticleId IdType="doi">10.1186/s13041-022-00914-x</ArticleId><ArticleId IdType="pii">10.1186/s13041-022-00914-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Savage AL, Schumann GG, Breen G, Bubb VJ, Al-Chalabi A, Quinn JP. Retrotransposons in the development and progression of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90(3):284&#x2013;293. doi: 10.1136/jnnp-2018-319210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319210</ArticleId><ArticleId IdType="pmc">PMC6518469</ArticleId><ArticleId IdType="pubmed">30305322</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews WD, Tuke PW, Al-Chalabi A, Gaudin P, Ijaz S, Parton MJ, et al. Detection of reverse transcriptase activity in the serum of patients with motor neurone disease. J Med Virol. 2000;61(4):527&#x2013;532. doi: 10.1002/1096-9071(200008)61:4&lt;527::AID-JMV17&gt;3.0.CO;2-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9071(200008)61:4&lt;527::AID-JMV17&gt;3.0.CO;2-A</ArticleId><ArticleId IdType="pubmed">10897073</ArticleId></ArticleIdList></Reference><Reference><Citation>Steele AJ, Al-Chalabi A, Ferrante K, Cudkowicz ME, Brown RH, Jr, Garson JA. Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. Neurology. 2005;64(3):454&#x2013;458. doi: 10.1212/01.WNL.0000150899.76130.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000150899.76130.71</ArticleId><ArticleId IdType="pubmed">15699374</ArticleId></ArticleIdList></Reference><Reference><Citation>Douville R, Liu J, Rothstein J, Nath A. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann Neurol. 2011;69(1):141&#x2013;151. doi: 10.1002/ana.22149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22149</ArticleId><ArticleId IdType="pmc">PMC3052883</ArticleId><ArticleId IdType="pubmed">21280084</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Lee MH, Henderson L, Tyagi R, Bachani M, Steiner J, et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med. 2015;7(307):307ra153. doi: 10.1126/scitranslmed.aac8201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aac8201</ArticleId><ArticleId IdType="pmc">PMC6344353</ArticleId><ArticleId IdType="pubmed">26424568</ArticleId></ArticleIdList></Reference><Reference><Citation>Garson JA, Usher L, Al-Chalabi A, Huggett J, Day EF, McCormick AL. Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2019;7(1):45. doi: 10.1186/s40478-019-0698-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0698-2</ArticleId><ArticleId IdType="pmc">PMC6421708</ArticleId><ArticleId IdType="pubmed">30885274</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer J, Harz C, Sanchez L, Pereira GC, Maldener E, Heras SR, et al. Transcriptional profiling of HERV-K(HML-2) in amyotrophic lateral sclerosis and potential implications for expression of HML-2 proteins. Mol Neurodegener. 2018;13(1):39. doi: 10.1186/s13024-018-0275-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0275-3</ArticleId><ArticleId IdType="pmc">PMC6091006</ArticleId><ArticleId IdType="pubmed">30068350</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Gonzales PK, Cook CN, Gendron TF, Daughrity LM, Song Y, et al. Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients. Hum Mol Genet. 2017;26(17):3421&#x2013;3431. doi: 10.1093/hmg/ddx233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx233</ArticleId><ArticleId IdType="pmc">PMC5886204</ArticleId><ArticleId IdType="pubmed">28637276</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH, Rozhkov NV, Shaw R, Kim D, Hubbard I, Fennessey S, et al. Postmortem cortex samples identify distinct molecular subtypes of ALS: retrotransposon activation, oxidative stress, and activated glia. Cell Rep. 2019;29(5):1164&#x2013;1177. doi: 10.1016/j.celrep.2019.09.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.066</ArticleId><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira GC, Sanchez L, Schaughency PM, Rubio-Roldan A, Choi JA, Planet E, et al. Properties of LINE-1 proteins and repeat element expression in the context of amyotrophic lateral sclerosis. Mob DNA. 2018;9:35. doi: 10.1186/s13100-018-0138-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13100-018-0138-z</ArticleId><ArticleId IdType="pmc">PMC6295051</ArticleId><ArticleId IdType="pubmed">30564290</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007;61(5):427&#x2013;434. doi: 10.1002/ana.21147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Jin Y, Prazak L, Hammell M, Dubnau J. Transposable elements in TDP-43-mediated neurodegenerative disorders. PLoS ONE. 2012;7(9):e44099. doi: 10.1371/journal.pone.0044099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0044099</ArticleId><ArticleId IdType="pmc">PMC3434193</ArticleId><ArticleId IdType="pubmed">22957047</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu EY, Russ J, Cali CP, Phan JM, Amlie-Wolf A, Lee EB. Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons. Cell Rep. 2019;27(5):1409&#x2013;1421. doi: 10.1016/j.celrep.2019.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.04.003</ArticleId><ArticleId IdType="pmc">PMC6508629</ArticleId><ArticleId IdType="pubmed">31042469</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, et al. Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci U S A. 2003;100(9):5280&#x2013;5285. doi: 10.1073/pnas.0831042100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0831042100</ArticleId><ArticleId IdType="pmc">PMC154336</ArticleId><ArticleId IdType="pubmed">12682288</ArticleId></ArticleIdList></Reference><Reference><Citation>Penzkofer T, Jager M, Figlerowicz M, Badge R, Mundlos S, Robinson PN, et al. L1Base 2: more retrotransposition-active LINE-1s, more mammalian genomes. Nucleic Acids Res. 2017;45(D1):D68&#x2013;D73. doi: 10.1093/nar/gkw925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw925</ArticleId><ArticleId IdType="pmc">PMC5210629</ArticleId><ArticleId IdType="pubmed">27924012</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Moran JV, Kazazian HH, Jr, Boeke JD. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell. 1996;87(5):905&#x2013;916. doi: 10.1016/S0092-8674(00)81997-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81997-2</ArticleId><ArticleId IdType="pubmed">8945517</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazina E, Weichenrieder O. Non-LTR retrotransposons encode noncanonical RRM domains in their first open reading frame. Proc Natl Acad Sci U S A. 2009;106(3):731&#x2013;736. doi: 10.1073/pnas.0809964106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0809964106</ArticleId><ArticleId IdType="pmc">PMC2630067</ArticleId><ArticleId IdType="pubmed">19139409</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathias SL, Scott AF, Kazazian HH, Jr, Boeke JD, Gabriel A. Reverse transcriptase encoded by a human transposable element. Science. 1991;254(5039):1808&#x2013;1810. doi: 10.1126/science.1722352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1722352</ArticleId><ArticleId IdType="pubmed">1722352</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner EJ, Lam VK, Harris DN, Chuang NT, Scott EC, Pittard WS, et al. The Mobile Element Locator Tool (MELT): population-scale mobile element discovery and biology. Genome Res. 2017;27(11):1916&#x2013;1929. doi: 10.1101/gr.218032.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.218032.116</ArticleId><ArticleId IdType="pmc">PMC5668948</ArticleId><ArticleId IdType="pubmed">28855259</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Martin B, Alvarez EG, Baez-Ortega A, Zamora J, Supek F, Demeulemeester J, et al. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. Nat Genet. 2020;52(3):306&#x2013;319. doi: 10.1038/s41588-019-0562-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0562-0</ArticleId><ArticleId IdType="pmc">PMC7058536</ArticleId><ArticleId IdType="pubmed">32024998</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh A, Macia A, Muotri AR. Transposable elements, inflammation, and neurological disease. Front Neurol. 2019;10:894. doi: 10.3389/fneur.2019.00894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00894</ArticleId><ArticleId IdType="pmc">PMC6710400</ArticleId><ArticleId IdType="pubmed">31481926</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH, Ostrow LW, Gale HM. Diseases of the nERVous system: retrotransposon activity in neurodegenerative disease. Mob DNA. 2019;10:32. doi: 10.1186/s13100-019-0176-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13100-019-0176-1</ArticleId><ArticleId IdType="pmc">PMC6659213</ArticleId><ArticleId IdType="pubmed">31372185</ArticleId></ArticleIdList></Reference><Reference><Citation>Savage AL, Lopez AI, Iacoangeli A, Bubb VJ, Smith B, Troakes C, et al. Frequency and methylation status of selected retrotransposition competent L1 loci in amyotrophic lateral sclerosis. Mol Brain. 2020;13(1):154. doi: 10.1186/s13041-020-00694-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-020-00694-2</ArticleId><ArticleId IdType="pmc">PMC7666467</ArticleId><ArticleId IdType="pubmed">33187550</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff AL, Bubb VJ, Quinn JP, Koks S. An Increased Burden of Highly Active Retrotransposition Competent L1s Is Associated with Parkinson's Disease Risk and Progression in the PPMI Cohort. Int J Mol Sci. 2020;21:18. doi: 10.3390/ijms21186562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21186562</ArticleId><ArticleId IdType="pmc">PMC7554759</ArticleId><ArticleId IdType="pubmed">32911699</ArticleId></ArticleIdList></Reference><Reference><Citation>McKerrow W, Fenyo D. L1EM: a tool for accurate locus specific LINE-1 RNA quantification. Bioinformatics. 2020;36(4):1167&#x2013;1173. doi: 10.1093/bioinformatics/btz724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btz724</ArticleId><ArticleId IdType="pmc">PMC8215917</ArticleId><ArticleId IdType="pubmed">31584629</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong HH, Yalamanchili HK, Guo C, Shulman JM, Liu Z. An ultra-fast and scalable quantification pipeline for transposable elements from next generation sequencing data. Pac Symp Biocomput. 2018;23:168&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pubmed">29218879</ArticleId></ArticleIdList></Reference><Reference><Citation>Rausch T, Zichner T, Schlattl A, Stutz AM, Benes V, Korbel JO. DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics. 2012;28(18):i333&#x2013;i339. doi: 10.1093/bioinformatics/bts378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts378</ArticleId><ArticleId IdType="pmc">PMC3436805</ArticleId><ArticleId IdType="pubmed">22962449</ArticleId></ArticleIdList></Reference><Reference><Citation>Penzkofer T, Dandekar T, Zemojtel T. L1Base: from functional annotation to prediction of active LINE-1 elements. Nucleic Acids Res. 2005;33:D498&#x2013;500. doi: 10.1093/nar/gki044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gki044</ArticleId><ArticleId IdType="pmc">PMC539998</ArticleId><ArticleId IdType="pubmed">15608246</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AR, Iacoangeli A, Adey BN, Bowles H, Shatunov A, Troakes C, et al. A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex. Sci Rep. 2021;11(1):14283. doi: 10.1038/s41598-021-93742-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93742-3</ArticleId><ArticleId IdType="pmc">PMC8275748</ArticleId><ArticleId IdType="pubmed">34253796</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachiller S, Del-Pozo-Martin Y, Carrion AM. L1 retrotransposition alters the hippocampal genomic landscape enabling memory formation. Brain Behav Immun. 2017;64:65&#x2013;70. doi: 10.1016/j.bbi.2016.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2016.12.018</ArticleId><ArticleId IdType="pubmed">28012829</ArticleId></ArticleIdList></Reference><Reference><Citation>Deininger P, Morales ME, White TB, Baddoo M, Hedges DJ, Servant G, et al. A comprehensive approach to expression of L1 loci. Nucleic Acids Res. 2017;45(5):e31. doi: 10.1093/nar/gkw1067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1067</ArticleId><ArticleId IdType="pmc">PMC5389711</ArticleId><ArticleId IdType="pubmed">27899577</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul T, Morales ME, Sartor AO, Belancio VP, Deininger P. Comparative analysis on the expression of L1 loci using various RNA-Seq preparations. Mob DNA. 2020;11:2. doi: 10.1186/s13100-019-0194-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13100-019-0194-z</ArticleId><ArticleId IdType="pmc">PMC6945437</ArticleId><ArticleId IdType="pubmed">31921361</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul T, Morales ME, Smither E, Baddoo M, Belancio VP, Deininger P. RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level. J Vis Exp. 2019;147:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7371004</ArticleId><ArticleId IdType="pubmed">31157783</ArticleId></ArticleIdList></Reference><Reference><Citation>Philippe C, Vargas-Landin DB, Doucet AJ, van Essen D, Vera-Otarola J, Kuciak M, et al. Activation of individual L1 retrotransposon instances is restricted to cell-type dependent permissive loci. Elife. 2016;5:e99. doi: 10.7554/eLife.13926.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.13926</ArticleId><ArticleId IdType="pmc">PMC4866827</ArticleId><ArticleId IdType="pubmed">27016617</ArticleId></ArticleIdList></Reference><Reference><Citation>Tubio JMC, Li Y, Ju YS, Martincorena I, Cooke SL, Tojo M, et al. Mobile DNA in cancer Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science. 2014;345(6196):1251343. doi: 10.1126/science.1251343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1251343</ArticleId><ArticleId IdType="pmc">PMC4380235</ArticleId><ArticleId IdType="pubmed">25082706</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewing AD, Smits N, Sanchez-Luque FJ, Faivre J, Brennan PM, Richardson SR, et al. Nanopore sequencing enables comprehensive transposable element epigenomic profiling. Mol Cell. 2020;80(5):915&#x2013;928. doi: 10.1016/j.molcel.2020.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.10.024</ArticleId><ArticleId IdType="pubmed">33186547</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>